Semaglutide

Struggling with weight loss on Ozempic? This article explores common reasons why you might not be seeing the results you expect and offers actionable advice.

Exploring the real-world weight loss results people are experiencing with Ozempic, beyond the clinical trials. Learn what to expect and how it compares to other weight management strategies.

In the UK, weight loss medications are prescribed through specific NHS and private pathways with defined eligibility criteria. This article explains which medications are available, who qualifies, what the evidence shows, and how pharmaceutical options differ from over-the-counter supplements.

Oprah Winfrey's public disclosure of using weight loss medication brought GLP-1 receptor agonists into mainstream conversation. This article examines what the clinical evidence shows about these medications, who qualifies for them, and what realistic expectations look like.

Approximately 14% of participants in the STEP 1 trial lost less than 5% body weight on semaglutide. Non-response and plateaus have specific causes: inadequate dose escalation, calorie intake above deficit despite reduced appetite, and metabolic adaptation. This article reviews what the evidence shows and what to do.